21 January 2018
News and Views
Links and Services
Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux esophagitis, reports the latest publication of the Alimentary Pharmacology & Therapeutics.
In patients with heartburn that persists despite proton pump inhibitor (PPI) therapy, reflux esop
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors